ArticleAmerican journal of cancer research2018

Cetuximab combined with natural killer cells therapy: an alternative to chemoradiotherapy for patients with advanced non-small cell lung cancer (NSCLC).

Shuzhen Liang et al.PubMed ↗Full text ↗

No numbers read from the abstract.